Log in
Sign up
Golden has been acquired by ComplyAdvantage.Read about it here ⟶
‌

US Patent 12123003 Synthetic RIG-I-like receptor agonists

Patent 12123003 was granted and assigned to Checkmate Pharmaceuticals on October, 2024 by the United States Patent and Trademark Office.

OverviewStructured DataIssuesContributorsActivity
Is a
Patent
Patent
0
Current Assignee
Checkmate Pharmaceuticals
Checkmate Pharmaceuticals
0
Date Filed
December 23, 2020
0
Date of Patent
October 22, 2024
0
Patent Applicant
Checkmate Pharmaceuticals
Checkmate Pharmaceuticals
0
Patent Application Number
17132448
0
Patent Citations
‌
US Patent 7943743 Human monoclonal antibodies to programmed death ligand 1 (PD-L1)
0
‌
US Patent 8008449 Human monoclonal antibodies to programmed death 1 (PD-1) and methods for treating cancer using anti-PD-1 antibodies alone or in combination with other immunotherapeutics
0
‌
US Patent 8354509 Antibodies to human programmed death receptor PD-1
0
‌
US Patent 8728474 Immunopotentiative composition
0
‌
US Patent 8779105 Monoclonal antibodies to programmed death 1 (PD-1)
0
‌
US Patent 8900587 Antibodies to human programmed death receptor PD-1
0
‌
US Patent 8952136 Antibodies to human programmed death receptor PD-1
0
‌
US Patent 9067999 Immunopotentiative composition
0
‌
US Patent 9073994 Immunopotentiative composition
0
‌
US Patent 9381208 Structure and use of 5′ phosphate oligonucleotides
0
•••
Patent Inventor Names
Aaron Jay Morris
0
Arthur M. Krieg
0
Patent Jurisdiction
United States Patent and Trademark Office
United States Patent and Trademark Office
0
Patent Number
12123003
0
Patent Primary Examiner
‌
Brian Whiteman
0

Find more entities like US Patent 12123003 Synthetic RIG-I-like receptor agonists

Use the Golden Query Tool to find similar entities by any field in the Knowledge Graph, including industry, location, and more.
Open Query Tool
Access by API
Golden Query Tool
Golden logo